Kalmanti M - Search Results

1

Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B.

Stournaras C, Stiakaki E, Koukouritaki SB, Theodoropoulos PA, Kalmanti M, Fostinis Y, Gravanis A. Stournaras C, et al. Among authors: kalmanti m. Biochem Pharmacol. 1996 Nov 8;52(9):1339-46. doi: 10.1016/s0006-2952(96)00389-9. Biochem Pharmacol. 1996. PMID: 8937443

2

High sensitivity of leukemic peripheral blood lymphocytes to triethyllead action.

Stiakaki E, Stournaras C, Dimitriou H, Kalmanti M. Stiakaki E, et al. Among authors: kalmanti m. Biochem Pharmacol. 1997 Dec 15;54(12):1371-6. doi: 10.1016/s0006-2952(97)00435-8. Biochem Pharmacol. 1997. PMID: 9393680

3

The role of L-carnitine on a restricted number of myeloid leukemia progenitor cells: generation of atypical cell types.

Vassiliadis S, Evangeliou A, Basta E, Dionyssopoulou E, Dimitriou H, Stiakaki E, Kalmanti M, Athanassakis I. Vassiliadis S, et al. Among authors: kalmanti m. Haematologia (Budap). 2002;32(4):341-53. Haematologia (Budap). 2002. PMID: 12803109

4

Childhood malignant diseases: which is the carnitine's role?

Rogalidou ME, Stiakaki E, Evangeliou A, Kalmanti M. Rogalidou ME, et al. Among authors: kalmanti m. J Pediatr Hematol Oncol. 2007 May;29(5):291-2. doi: 10.1097/MPH.0b013e318055644b. J Pediatr Hematol Oncol. 2007. PMID: 17483703 Review. No abstract available.

5

Amifostine as differentiating agent in cord blood and bone marrow cultures from children with hematological disorders.

Danilatou V, Dimitriou H, Stiakaki E, Kalmanti M. Danilatou V, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 2004 Mar;21(2):125-34. doi: 10.1080/08880010490272984. Pediatr Hematol Oncol. 2004. PMID: 15160511

6

Evaluation of bone mineral density at different phases of therapy of childhood all.

Maniadaki I, Stiakaki E, Germanakis I, Kalmanti M. Maniadaki I, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):11-8. doi: 10.1080/08880010500313272. Pediatr Hematol Oncol. 2006. PMID: 16326407 Clinical Trial.

7

In vitro proliferative and differentiating characteristics of CD133(+) and CD34(+) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO). Potential implications for hematopoietic cell transplantation.

Dimitriou H, Vorgia P, Stiakaki E, Mavroudis D, Markaki EA, Koumantakis E, Kalmanti M. Dimitriou H, et al. Among authors: kalmanti m. Leuk Res. 2003 Dec;27(12):1143-51. doi: 10.1016/s0145-2126(03)00107-3. Leuk Res. 2003. PMID: 12921953

8

Infectious toxicity of dexamethasone during all remission-induction chemotherapy: report of two cases and literature review.

Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M. Mantadakis E, et al. Among authors: kalmanti m. Pediatr Hematol Oncol. 2004 Jan-Feb;21(1):27-35. Pediatr Hematol Oncol. 2004. PMID: 14660304

9

T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.

Mantadakis E, Danilatou V, Stiakaki E, Paterakis G, Papadhimitriou S, Kalmanti M. Mantadakis E, et al. Among authors: kalmanti m. Pediatr Blood Cancer. 2007 Mar;48(3):354-7. doi: 10.1002/pbc.20543. Pediatr Blood Cancer. 2007. PMID: 16206214

10

Serum carnitine levels in childhood leukemia.

Rogalidou M, Evangeliou A, Stiakaki E, Giahnakis E, Kalmanti M. Rogalidou M, et al. Among authors: kalmanti m. J Pediatr Hematol Oncol. 2010 Mar;32(2):e61-9. doi: 10.1097/MPH.0b013e3181ca9eb9. J Pediatr Hematol Oncol. 2010. PMID: 20168247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters